At a time when India has approved two coronavirus vaccines for emergency use, a controversy has broken out after several critics said the approvals were rushed. NDTV's Uma Sudhir spoke to Dr Rakesh Mishra, director of the Hyderabad-based Centre for Cellular and Molecular Biology (CCMB), who says, "We must trust regulatory body that gave emergency use approval to Covid vaccines." He points out that both the firms - that are developing Covishield and Covaxin - are powerhouses for vaccines with proven track record, adding that the controversy is "unfortunate and unnecessary".
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
- Category
- Asia
- Tags
- NDTV 24x7, Coronavirus, Covid-19
Sign in or sign up to post comments.
Be the first to comment